Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TRANSGAMING
(TSV:
TNG
)
0.0950
CAD
UNCHANGED
Streaming Delayed Price
/ Updated:
4:50 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
41,860
Open
0.0900
Bid (Size)
0.0950 (0)
Ask (Size)
0.1000 (0)
Prev. Close
0.0950
Today's Range
0.0900 - 0.0950
52wk Range
0.0550 - 0.4100
Shares Outstanding
80,261,548
Dividend Yield
N/A
Top News
More News
Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
May 21, 2013
from
Business Wire News Releases
Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives
May 17, 2013
from
Business Wire News Releases
More News
Read More
TransGaming Launches Exclusive GameTree(TM) TV World Poker Tour(R) Game on the Freebox Revolution
May 14, 2013
from
Marketwired
TransGaming Launches Exclusive GameTree(TM) TV World Poker Tour(R) Game on the Freebox Revolution
May 14, 2013
from
Marketwired News Releases
TransGaming Q&A Call on Fiscal Year 2013 Third Quarter Results
May 01, 2013
from
Marketwired
TransGaming Q&A Call on Fiscal Year 2013 Third Quarter Results
May 01, 2013
from
Marketwired News Releases
TransGaming Reports Fiscal Year 2013 Third Quarter Results
April 29, 2013
from
Marketwired News Releases
TransGaming Reports Fiscal Year 2013 Third Quarter Results
April 29, 2013
from
Marketwired
Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013
April 29, 2013
from
Business Wire News Releases
Transgene: Promising Final Data from the Phase 2 HCVac Trial of TG4040 Presented at EASL 2013
April 29, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here